Matthew Harrion

Pfizer, Inc. (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) suffered a setback last week after a FDA panel did not recommend a third dose of the duo's COVID-19 vaccine for the broader population. The Pfizer-BioNTech Analysts: Morgan Stanley analyst Matthew Harrison maintained an Equal-weight rating...